You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Merck
McKesson
Mallinckrodt
Boehringer Ingelheim

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

NORPACE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Norpace, and when can generic versions of Norpace launch?

Norpace is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in NORPACE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.

Drug patent expirations by year for NORPACE
Drug Prices for NORPACE

See drug prices for NORPACE

Recent Clinical Trials for NORPACE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MedtronicPhase 3
Mayo ClinicPhase 3

See all NORPACE clinical trials

Pharmacology for NORPACE
Drug ClassAntiarrhythmic

US Patents and Regulatory Information for NORPACE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer NORPACE disopyramide phosphate CAPSULE;ORAL 017447-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pfizer NORPACE CR disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 018655-002 Jul 20, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Pfizer NORPACE disopyramide phosphate CAPSULE;ORAL 017447-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Moodys
McKinsey
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.